Vitamin D may be a link to black-white disparities in adverse birth outcomes

Obstetrical and Gynecological Survey

Volumn 65, Issue 4, 2010, Pages 273-284

  Bodnar, Lisa M ^a   Simhan, Hyagriv N ^b,c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; MINERAL; MULTIVITAMIN; VITAMIN D;

CLINICAL TRIAL; FETUS GROWTH; GROWTH RATE; HUMAN; INTRAUTERINE GROWTH RETARDATION; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; RACE DIFFERENCE; REVIEW; VITAMIN D DEFICIENCY; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77951684960     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3181dbc55b     Document Type: Review

References (142)

1. MacDorman MF, Mathews TJ. Recent trends in infant mortality in the United States. NCHS Data Brief 2008:1-8.
2. MacDorman MF, Kirmeyer S. Fetal and perinatal mortality, United States, 2005. Natl Vital Stat Rep 2009;57:1-19.
3. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2006. Natl Vital Stat Rep 2009;57:1-104.
4. Niswander K, ed. The Women and Their Pregnancies: The Collaborative Perinatal Study of the National Institute of Neurological Diseases and Stroke. Philadelphia, PA: WB Saunders, 1972.
5. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991;266:237-241.
6. Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003;22:203-212.
7. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97:533-538.
8. Getahun D, Nath C, Ananth CV, et al. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol 2008;198:525. e1-e5.
9. Haddad JG, Stamp TC. Circulating 25-hydroxyvitamin D in man. Am J Med 1974;57:57-62.
10. Hollis BW. Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int 1996;58:4-5.
11. Seamans KM, Cashman KD. Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr 2009;89:1997S-2008S.
12. Hollis BW, Pittard WB III. Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences. J Clin Endocrinol Metab 1984;59:652-657.
13. Bodnar LM, Simhan HN, Powers RW, et al. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 2007;137:447-452.
14. Salle BL, Delvin EE, Lapillonne A, et al. Perinatal metabolism of vitamin D.Am J Clin Nutr 2000;71(suppl 5):1317S-1324S.
15. Weisman Y, Harell A, Edelstein S, et al. 1 alpha, 25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature 1979;281: 317-319.
16. Hewison M, Burke F, Evans KN, et al. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 2007;103:316-321.
17. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged 60 y. Am J Clin Nutr 2004;80:752-758.
18. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713-716.
19. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362-371.
20. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135:317-322.
21. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80(suppl 6):1678S-1688S.
22. Holick MF. Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables. Fed Proc 1987;46: 1876-1882.
23. Clemens TL, Adams JS, Henderson SL, et al. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982;1:74-76.
24. Matsuoka LY, Ide L, Wortsman J, et al. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987;64:1165-1168.
25. Santmyire BR, Feldman SR, Fleischer AB Jr. Lifestyle high-risk behaviors and demographics may predict the level of participation in sun-protection behaviors and skin cancer primary prevention in the United States: results of the 1998 National Health Interview Survey. Cancer 2001;92:1315-1324.
26. Hall HI, Rogers JD. Sun protection behaviors among African Americans. Ethn Dis 1999;9:126-131.
27. Lu Z, Chen TC, Kline L. Photosynthesis of previtamin D3 in cities around the world. In: Holick MF, Kligman A, eds. Biologic Effects of Light. Berlin, Germany: Walter De Gruyter & Company,ý 1992:48-51.
28. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988;67:373-378.
29. Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 2004;80(suppl 6):1710S-1716S.
30. Moore CE, Murphy MM, Holick MF. Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr 2005;135:2478-2485.
31. Calvo MS, Whiting SJ. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev 2003;61:107-113.
32. Lehtonen-Veromaa M, Mottonen T, Irjala K, et al. Vitamin D intake is low and hypovitaminosis D common in healthy 9-to 15-year-old Finnish girls. Eur J Clin Nutr 1999;53: 746-751.
33. Vieth R, Cole DE, Hawker GA, et al. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 2001;55:1091-1097.
34. Heaney RP, Davies KM, Chen TC, et al. Human serum 25- hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-210.
35. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-856.
36. Dawson-Hughes B, Lips P, Holick MF, et al. Vitamin D round table. In: Dawson-Hughes B, Heaney RP, eds. Nutritional Aspects of Osteoporosis. New York, NY: Academic Press, 2004.
37. Vieth R. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004;89-90:575-579.
38. Hollis BW. Vitamin D requirement during pregnancy and lactation. J Bone Miner Res 2007;22(suppl 2):V39-V44.
39. Looker AC, Pfeiffer CM, Lacher DA, et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008;88:1519-1527.
40. Lee JM, Smith JR, Philipp BL, et al. Vitamin D deficiency in a healthy group of mothers and newborn infants. Clin Pediatr 2007;46:42-44.
41. van der Meer IM, Karamali NS, Boeke AJ, et al. High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands. Am J Clin Nutr 2006;84: 350-353.
42. Brunvand L, Haug E. Vitamin D deficiency amongst Pakistani women in Oslo. Acta Obstet Gynecol Scand 1993;72:264-268.
43. Henriksen C, Brunvand L, Stoltenberg C, et al. Diet and vitamin D status among pregnant Pakistani women in Oslo. Eur J Clin Nutr 1995;49:211-218.
44. Pehlivan I, Hatun S, Aydogan M, et al. Maternal vitamin D deficiency and vitamin D supplementation in healthy infants. Turk J Pediatr 2003;45:315-320.
45. Sachan A, Gupta R, Das V, et al. High prevalence of vitamin D deficiency among pregnant women and their newborns in northern India. Am J Clin Nutr 2005;81:1060-1064.
46. Goswami R, Gupta N, Goswami D, et al. Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr 2000;72:472-475.
47. DeLuca HF. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J 1988;2:224-236.
48. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357: 266-281.
49. McGrath J. Does 'imprinting' with low prenatal vitamin D contribute to the risk of various adult disorders? Med Hypotheses 2001;56:367-371.
50. Mahomed K, Gulmezoglu AM. Vitamin D supplementation in pregnancy. Cochrane Database Syst Rev 2000:CD000228.
51. Henry HL, Norman AW. Vitamin D: metabolism and biological actions. Annu Rev Nutr 1984;4:493-520.
52. Huppertz B, Peeters LL. Vascular biology in implantation and placentation. Angiogenesis 2005;8:157-167.
53. Dimitriadis E, White CA, Jones RL, et al. Cytokines, chemo-kines and growth factors in endometrium related to implantation. Hum Reprod Update 2005;11:613-630.
54. Spencer TE, Johnson GA, Bazer FW, et al. Implantation mechanisms: insights from the sheep. Reproduction 2004; 128:657-668.
55. Evans KN, Bulmer JN, Kilby MD, et al. Vitamin D and pla-cental-decidual function. J Soc Gynecol Investig 2004;11: 263-271.
56. Daftary GS, Taylor HS. Endocrine regulation of HOX genes. Endocr Rev 2006;27:331-355.
57. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005;46:1243-1249.
58. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180(2 pt 1):499-506.
59. Hewison M. Vitamin D and the immune system. J Endocrinol 1992;132:173-175.
60. Rigby WF. The immunobiology of vitamin D. Immunol Today 1988;9:54-58.
61. Diaz L, Noyola-Martinez N, Barrera D, et al. Calcitriol inhibits TNF-alpha-induced inflammatory cytokines in human tro-phoblasts. J Reprod Immunol 2009;81:17-24.
62. Braam LA, Hoeks AP, Brouns F, et al. Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Hae-most 2004;91:373-380.
63. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997; 30(2 pt 1):150-156.
64. Krause R, Buhring M, Hopfenmuller W, et al. Ultraviolet B and blood pressure. Lancet 1998;352:709-710.
65. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-238.
66. Maynard SE, Venkatesha S, Thadhani R, et al. Soluble fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res 2005;57:1R-7R.
67. Cardus A, Parisi E, Gallego C, et al. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 2006;69: 1377-1384.
68. Levine MJ, Teegarden D. 1 a,25-dihydroxycholecalciferol increases the expression of vascular endothelial growth factor in C3H10T1/2 mouse embryo fibroblasts. J Nutr 2004;134: 2244-2250.
69. Wang Y, Zhou J, Minto AW, et al. Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy. Kidney Int 2006;70: 882-891.
70. Wolf M, Sandler L, Munoz K, et al. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 2002;87:1563-1568.
71. Labriji-Mestaghanmi H, Billaudel B, Garnier PE, et al. Vitamin D and pancreatic islet function. I. Time course for changes in insulin secretion and content during vitamin D deprivation and repletion. J Endocrinol Invest 1988;11:577-584.
72. Hypponen E. Vitamin D for the prevention of preeclampsia? A hypothesis. Nutr Rev 2005;63:225-232.
73. Lapillonne A. Vitamin D deficiency during pregnancy may impair maternal and fetal outcomes. Med Hypotheses 2010; 74:71-75.
74. Olsen SF, Secher NJ. A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial. Br J Nutr 1990;64:599-609.
75. J Obstet Gynaecol Br Emp,1946,53,498-509
76. People's League of Health. The nutrition of expectant and nursing mothers in relation to maternal and infant mortality and morbidity. J Obstet Gynaecol Br Emp 1946;53:498-509.
77. Marya RK, Rathee S, Manrow M. Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecol Obstet Invest 1987;24:38-42.
78. Bodnar LM, Catov JM, Simhan HN, et al. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007;92:3517-3522.
79. Haugen M, Brantsaeter AL, Trogstad L, et al. Vitamin D supplementation and reduced risk of preeclampsia in nullip-arous women. Epidemiology 2009;20:720-726.
80. Olafsdottir AS, Magnusardottir AR, Thorgeirsdottir H, et al. Relationship between dietary intake of cod liver oil in early pregnancy and birthweight. BJOG 2005;112:424-429.
81. Oken E, Ning Y, Rifas-Shiman SL, et al. Diet during pregnancy and risk of preeclampsia or gestational hypertension. Ann Epidemiol 2007;17:663-668.
82. Holden JM, Lemar LE. Assessing vitamin D contents in foods and supplements: challenges and needs. Am J Clin Nutr 2008;88:551S-553S.
83. Millen AE, Bodnar LM. Vitamin D assessment in population-based studies: a review of the issues. Am J Clin Nutr 2008; 87:1102S-1105S.
84. Hypponen E, Hartikainen AL, Sovio U, et al. Does vitamin D supplementation in infancy reduce the risk of pre-eclampsia? Eur J Clin Nutr 2007;61:1136-1139.
85. Hofmeyr GJ, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2006: CD001059.
86. Wharton B, Bishop N. Rickets. Lancet 2003;362:1389-1400.
87. Bodnar LM, Catov JM, Roberts JM. Racial/ethnic differences in the monthly variation of preeclampsia incidence. Am J Obstet Gynecol 2007;196:324.e1-324. e5.
88. Magnus P, Eskild A. Seasonal variation in the occurrence of pre-eclampsia. BJOG 2001;108:1116-1119.
89. Phillips JK, Bernstein IM, Mongeon JA, et al. Seasonal variation in preeclampsia based on timing of conception. Obstet Gynecol 2004;104(5 pt 1):1015-1020.
90. Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 1998;147: 1062-1070.
91. Romero R, Mazor M, Munoz H, et al. The preterm labor syndrome. Ann N Y Acad Sci 1994;734:414-429.
92. Dudley DJ. Immunoendocrinology of preterm labor: the link between corticotropin-releasing hormone and inflammation. Am J Obstet Gynecol 1999;180(1 pt 3):S251-S256.
93. Lockwood CJ, Kuczynski E. Risk stratification and pathological mechanisms in preterm delivery. Paediatr Perinat Epidemiol 2001;15(suppl 2):78-89.
94. Muller K, Diamant M, Bendtzen K. Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3. Immunol Lett 1991;28:115-120.
95. Muller K, Odum N, Bendtzen K. 1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol Lett 1993;35:177-182.
96. Oelzner P, Franke S, Muller A, et al. Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis. Rheumatology (Oxford) 1999;38:841-847.
97. Helming L, Bose J, Ehrchen J, et al. 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macro-phage activation. Blood 2005;106:4351-4358.
98. Liu N, Kaplan AT, Low J, et al. Vitamin D induces innate antibacterial responses in human trophoblasts via an intra-crine pathway. Biol Reprod 2009;80:398-406.
99. Evans KN, Nguyen L, Chan J, et al. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cyto-kine production by human decidual cells. Biol Reprod 2006; 75:816-822.
100. Buxton IL. Regulation of uterine function: a biochemical conundrum in the regulation of smooth muscle relaxation. Mol Pharmacol 2004;65:1051-1059.
101. Wray S, Kupittayanant S, Shmygol A, et al. The physiological basis of uterine contractility: a short review. Exp Physiol 2001;86:239-246.
102. Tribe RM. Regulation of human myometrial contractility during pregnancy and labour: are calcium homeostatic pathways important? Exp Physiol 2001;86:247-254.
103. Delorme AC, Danan JL, Acker MG, et al. In rat uterus 17 beta-estradiol stimulates a calcium-binding protein similar to the duodenal vitamin D-dependent calcium-binding protein. Endocrinology 1983;113:1340-1347.
104. Morley R, Carlin JB, Pasco JA, et al. Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size. J Clin Endocrinol Metab 2006;91: 906-912.
105. Mehta S, Hunter DJ, Mugusi FM, et al. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis 2009;200:1022-1030.
106. Bodnar LM, Simhan HN. The prevalence of preterm birth and season of conception. Paediatr Perinat Epidemiol 2008;22: 538-545.
107. Bodnar LM, Krohn MA, Simhan HN. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr 2009;139:1157-1161.
108. Meis PJ, Goldenberg RL, Mercer B, et al. The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1995;173:1231-1235.
109. Legro RS. Insulin resistance in women's health: why it matters and how to identify it. Curr Opin Obstet Gynecol 2009; 21:301-305.
110. Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet 2009;373:1789-1797.
111. Billaudel B, Labriji-Mestaghanmi H, Sutter BC, et al. Vitamin D and pancreatic islet function. II. Dynamics of insulin release and cationic fluxes. J Endocrinol Invest 1988;11:585-593.
112. Boucher BJ, Mannan N, Noonan K, et al. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 1995;38: 1239-1245.
113. Ford ES, Ajani UA, McGuire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-1230.
114. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-825.
115. Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-2029. (Pubitemid 46997093)
116. Zhang C, Qiu C, Hu FB, et al. Maternal plasma 25-hydroxyvitamin d concentrations and the risk for gestational diabetes mellitus. PLoS One 2008;3:e3753.
117. Maghbooli Z, Hossein-Nezhad A, Karimi F, et al. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev 2008;24:27-32.
118. Clifton-Bligh RJ, McElduff P, McElduff A. Maternal vitamin D deficiency, ethnicity and gestational diabetes. Diabet Med 2008;25:678-684.
119. Farrant HJ, Krishnaveni GV, Hill JC, et al. Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size. Eur J Clin Nutr 2009;63:646-652.
120. Barrera D, Avila E, Hernandez G, et al. Calcitriol affects hCG gene transcription in cultured human syncytiotrophoblasts. Reprod Biol Endocrinol 2008;6:3.
121. Barrera D, Avila E, Hernandez G, et al. Estradiol and progesterone synthesis in human placenta is stimulated by calcitriol. J Steroid Biochem Mol Biol 2007;103:529-532.
122. Sayers A, Tobias JH. Estimated maternal ultraviolet B exposure levels in pregnancy influence skeletal development of the child. J Clin Endocrinol Metab 2009;94:765-771.
123. Mahon P, Harvey N, Crozier S, et al. Low maternal vitamin D status and fetal bone development: cohort study. J Bone Miner Res 2009;25:14-19.
124. Brooke OG, Brown IR, Bone CD, et al. Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. BMJ 1980;280:751-754.
125. Marya RK, Rathee S, Lata V, et al. Effects of vitamin D supplementation in pregnancy. Gynecol Obstet Invest 1981; 12:155-161.
126. Marya RK, Rathee S, Dua V, et al. Effect of vitamin D supplementation during pregnancy on foetal growth. Indian J Med Res 1988;88:488-492.
127. Mallet E, Gugi B, Brunelle P, et al. Vitamin D supplementation in pregnancy: a controlled trial of two methods. Obstet Gy-necol 1986;68:300-304.
128. Mannion CA, Gray-Donald K, Koski KG. Association of low intake of milk and vitamin D during pregnancy with decreased birth weight. CMAJ 2006;174:1273-1277.
129. Sabour H, Hossein-Nezhad A, Maghbooli Z, et al. Relationship between pregnancy outcomes and maternal vitamin D and calcium intake: a cross-sectional study. Gynecol Endo-crinol 2006;22:585-589.
130. Bodnar LM, Catov JM, Zmuda JM, et al. Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age birth. J Nutr. In press.
131. Morley R, Carlin JB, Pasco JA, et al. Maternal 25-hydroxyvitamin D concentration and offspring birth size: effect modification by infant VDR genotype. Eur J Clin Nutr 2009;63:802-804.
132. Brunvand L, Quigstad E, Urdal P, et al. Vitamin D deficiency and fetal growth. Early Hum Dev 1996;45:27-33.
133. Prentice A, Jarjou LM, Goldberg GR, et al. Maternal plasma 25-hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paedi-atr 2009;98:1360-1362.
134. Gale CR, Robinson SM, Harvey NC, et al. Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr 2008;62:68-77.
135. Bloomfield FH, Harding JE. Experimental aspects of nutrition and fetal growth. Fetal Matern Med Rev 1998;10:91-107.
136. Zhang X, Platt RW, Cnattingius S, et al. The use of customised versus population-based birthweight standards in predicting perinatal mortality. BJOG 2007;114:474-477. (Pubitemid 46393305)
137. Gardosi J, Francis A. Adverse pregnancy outcome and association with small for gestational age birthweight by customized and population-based percentiles. Am J Obstet Gy-necol 2009;201:28.e1-28.e8.
138. Gardosi J, Clausson B, Francis A. The value of customised centiles in assessing perinatal mortality risk associated with parity and maternal size. BJOG 2009;116:1356-1363.
139. Smith GC, Fretts RC. Stillbirth. Lancet 2007;370:1715-1725.
140. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27:2813-2818.
141. Bell NH, Greene A, Epstein S, et al. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985; 76:470-473. (Pubitemid 15227507)
142. Cosman F, Nieves J, Dempster D, et al. Vitamin D economy in blacks. J Bone Miner Res 2007;22(suppl 2):V34-V38.